Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Blood|January 17, 2004
Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type mattersMaha El-Zimaity, Rima Saliba, Kawah Chan, et al.
Blood|April 20, 2004
Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantationMarcos de Lima, Athanasios Anagnostopoulos, Mark Munsell, et al.
Haematologica|May 5, 2018
Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemiaGail J Roboz, Ellen K Ritchie, Yulia Dault, et al.
Blood|April 8, 2004
Tumor necrosis factor-alpha blockade for the treatment of acute GVHDDaniel Couriel, Rima Saliba, Krystal Hicks, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 3, 2004
Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantationDaniel R Couriel, Rima M Saliba, Sergio Giralt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 3, 2003
West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature reviewDavid S Hong, Kalen L Jacobson, Issam I Raad, et al.
Blood|July 5, 2003
Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 yearsRaymond Wong, Sergio A Giralt, Thomas Martin, et al.
JCO Oncology Practice|September 30, 2024
Pharmacist-Led Video Consultation to Identify and Mitigate Drug Interactions Among Patients Initiating Oral Anticancer DrugsMorgan R L Lichtenstein, Peter Campbell, Rohit Raghunathan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 2005
Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantationRaymond Wong, Munir Shahjahan, Xuemei Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 19, 2002
Use of thrombopoietin in combination with chemotherapy and granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilizationJames L Gajewski, Gabriela Rondon, Michele L Donato, et al.
Pageof 2